
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas
Robert Roskoski
Pharmacological Research (2024) Vol. 203, pp. 107181-107181
Open Access | Times Cited: 10
Robert Roskoski
Pharmacological Research (2024) Vol. 203, pp. 107181-107181
Open Access | Times Cited: 10
Showing 10 citing articles:
F-box protein FBXO21 overexpression inhibits the proliferation and metastasis of clear cell renal cell carcinoma and is closely related to the CREB pathway and tumor immune cell infiltration
Wuping Yang, Taile Jing, Cunjin Wu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Wuping Yang, Taile Jing, Cunjin Wu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Increased ZNF83 is a potential prognostic biomarker and regulates oxidative stress-induced ferroptosis in clear cell renal cell carcinoma
Zhaojie Lyu, Huming Wang, Fang Dai, et al.
Journal of Molecular Medicine (2025)
Closed Access
Zhaojie Lyu, Huming Wang, Fang Dai, et al.
Journal of Molecular Medicine (2025)
Closed Access
Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma
Ilya Tsimafeyeu, А. В. Султанбаев, Д. М. Дубовиченко, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Ilya Tsimafeyeu, А. В. Султанбаев, Д. М. Дубовиченко, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Properties of FDA-approved small molecule protein kinase inhibitors: a 2025 update
Robert Roskoski
Pharmacological Research (2025), pp. 107723-107723
Open Access
Robert Roskoski
Pharmacological Research (2025), pp. 107723-107723
Open Access
Three-Dimensional Printing Creates New Trends of the Technological Revolution in Urologic Surgery
Ruicheng Wu, Jie Wang, Dengxiong Li, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 8, pp. 3414-3435
Open Access | Times Cited: 2
Ruicheng Wu, Jie Wang, Dengxiong Li, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 8, pp. 3414-3435
Open Access | Times Cited: 2
Ferroptosis-associated genes and compounds in renal cell carcinoma
Chengwu He, Qingyi Li, Weijia Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Chengwu He, Qingyi Li, Weijia Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Cerbera odollam fruit extracts enhance anti-cancer activity of sorafenib in HCT116 and HepG2 cells
Supawadee Parhira, Orakot Simanurak, Khemmachat Pansooksan, et al.
Chinese Herbal Medicines (2024) Vol. 17, Iss. 1, pp. 108-126
Open Access | Times Cited: 1
Supawadee Parhira, Orakot Simanurak, Khemmachat Pansooksan, et al.
Chinese Herbal Medicines (2024) Vol. 17, Iss. 1, pp. 108-126
Open Access | Times Cited: 1
Kidney cancer: From tumor biology to innovative therapeutics
Laura Rinaldi, Emanuela Senatore, Stella Feliciello, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189240-189240
Open Access | Times Cited: 1
Laura Rinaldi, Emanuela Senatore, Stella Feliciello, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189240-189240
Open Access | Times Cited: 1
Co‑occurrence of clear cell renal cell carcinoma and bladder urothelial carcinoma: A case report and literature review
Shuo Wu, Yuliang Zuo, Meihong Ye, et al.
Oncology Letters (2024) Vol. 29, Iss. 1
Open Access
Shuo Wu, Yuliang Zuo, Meihong Ye, et al.
Oncology Letters (2024) Vol. 29, Iss. 1
Open Access
Comprehensive single-cell and bulk transcriptomic analyses to develop an NK cell-derived gene signature for prognostic assessment and precision medicine in breast cancer
Qianshan Hou, Chunzhen Li, Y.M. Chong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Qianshan Hou, Chunzhen Li, Y.M. Chong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Monoclonal Antibody Therapies in Cancer Immunotherapy
Charuwan Thanawiroon, Bancha Yingngam
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 419-472
Closed Access
Charuwan Thanawiroon, Bancha Yingngam
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 419-472
Closed Access